MBMelike Bektaş

Melike Bektaş

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melike Bektaş has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Olgularla Yoğun Bakım II

    by Ahmet Bindal, Erkan Çakmak, Oya Olcay Özdeş, Tuğçe Gazioğlu Kişi, Özümcan Akkoç, E. Büşra Berilgen Kaya, Aysun Yıldız Altun, Havin Şahin, Rahmet Yıldırım, Canan Akman, et al.

  • Trombolitik Kontrendike Masif Pulmoner Embolide Embolektomi Olgusu

    by Hüseyin Arıkan, Melike Bektaş

    Bu bölüm, trombolitik tedavinin kontrendike olduğu masif pulmoner emboli (PE) olgusunda cerrahi embolektomi yaklaşımını, güncel literatür ve yoğun bakım perspektifi eşliğinde ele almaktadır. Pulmoner embolinin epidemiyolojisi, risk faktörleri, klinik bulguları ve ESC kılavuzlarına dayalı risk sınıflaması ayrıntılı biçimde sunulmakta; özellikle sağ ventrikül disfonksiyonu, biyobelirteçler ve hemodinamik instabilitenin prognozdaki rolü vurgulanmaktadır. Tanısal algoritmada CTPA, ekokardiyografi ve kritik hastada POCUS’un yeri tartışılmaktadır. Yüksek riskli PE’de organ desteği, oksijen tedavisi, sıvı yönetimi ve vazopresör kullanımı gibi yoğun bakım stratejileri açıklanmakta; antikoagülasyon ve fibrinoliz endikasyonları gözden geçirilmektedir. Trombolizin kontrendike olduğu veya başarısız kaldığı durumlarda cerrahi embolektomi, VA-ECMO ve kateter-yönlendirmeli tedaviler gibi alternatif reperfüzyon yöntemleri değerlendirilmiştir. Sunulan olgu, spinal cerrahi sonrası gelişen ve fibrinoliz uygulanamayan masif PE’de başarılı cerrahi embolektomi ile klinik iyileşmeyi göstermektedir. Bölüm, kritik PE yönetiminde multidisipliner yaklaşımın önemini vurgulamaktadır. This chapter presents the management of massive pulmonary embolism (PE) when thrombolytic therapy is contraindicated, focusing on a case treated with surgical embolectomy. Epidemiology, risk factors, and ESC-based risk stratification are reviewed, with particular emphasis on right ventricular dysfunction, biomarkers, and hemodynamic instability as key prognostic determinants. The diagnostic approach highlights the roles of CTPA, echocardiography, and point-of-care ultrasound in critically ill patients. Intensive care strategies—including oxygen support, fluid management, vasopressor use, and organ support—are discussed in the context of high-risk PE. The indications and limitations of anticoagulation and fibrinolysis are outlined, followed by alternative reperfusion strategies such as surgical embolectomy, VA-ECMO, and catheter-directed therapies. The presented case illustrates successful surgical management of massive PE in a patient with recent spinal surgery, where thrombolysis was contraindicated. The chapter underscores the importance of rapid risk stratification, timely reperfusion decisions, and a multidisciplinary PE response approach in critically ill patients.

  • Open Access

    Characteristics and mortality determinants of COVID-19 patients undergoing hemodialysis

    by Savaş SİPAHİ, Hamad Dhei̇r, Aysel Toçoğlu, Melike Bektaş, Seyyid Bilal Açikgöz, Ahmet Cihat Genç, Fuldem Mutlu, Mehmet Köroğlu, Ali Fuat Erdem, Oğuz Karabay

    Background/aim: The COVID-19 infection, which started in Wuhan City, China, in December 2019, turned into a pandemic in a very short time, affecting mainly the elderly and those with serious chronic illnesses. COVID-19 infections have been observed to have a high mortality rate, especially in patients undergoing maintenance hemodialysis. Materials and methods: Forty-two patients over 18 years of age who underwent a maintenance hemodialysis program at our unit, who tested positive for COVID-19 by PCR from nasopharyngeal swabs, and/or who were observed to have disease-related signs in their CTs were included in the study. Results: In this study, 23 of 42 patients receiving hemodialysis support in our clinic were included. The median age was 67 years old (min: 35; max: 91 years), and all of our patients had primary hypertension and other comorbidities. Their clinical evaluation showed that dry cough (47.8%) and shortness of breath (47.8%) were the most common symptoms. Fever was less pronounced (30.4%). The median time from the onset of symptoms to hospitalization was 1 day (min: 0; max:), and the time from hospitalization to death was 18 days (min: 1; max: 22). Transfer from the inpatient ward to the ICU took a median of 7 days (min: 1; max: 13). Among the 23 patients, 3 died during follow-up, and 20 were discharged with full recovery. Baseline ferritin, procalcitonin levels, and CRP/albumin rates were higher, and neutrophil/lymphocyte levels were lower in patients who eventually died. In these patients, despite being nonsignificant, there were more diabetic patients, and the D-dimer levels were higher than 1000 ugFEU/L. Conclusion: The COVID-19 infection is associated with increased mortality in chronic kidney diseases patients. Despite being nonsignificant, there was a trend towards increased mortality in patient with diabetes, D-dimer levels >1000 ugFEU/L, higher ferritin and prokalsitonin levels, an increased CRP/albumin ratio, and a lower neutrophil/lymphocyte ratio.